Drug Shortage Report for BUDESONIDE
| Report ID | 204928 |
| Drug Identification Number | 02483874 |
| Brand name | BUDESONIDE |
| Common or Proper name | Budesonide Controlled Ileal Release Capsules 3 mg |
| Company Name | TILLOTTS PHARMA GMBH |
| Market Status | MARKETED |
| Active Ingredient(s) | BUDESONIDE |
| Strength(s) | 3MG |
| Dosage form(s) | CAPSULE (EXTENDED RELEASE) CAPSULE (SUSTAINED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | A07EA |
| ATC description | INTESTINALANTIINFLAMMATORY AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2023-09-06 |
| Actual start date | 2023-09-13 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2023-09-22 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | WARMBACHER STRASSE 80 RHEINFELDEN, BADEN-WUERTTEMBERG GERMANY 79618 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2023-09-22 | French | Compare |
| v3 | 2023-09-22 | English | Compare |
| v2 | 2023-09-22 | French | Compare |
| v1 | 2023-09-22 | English | Compare |
Showing 1 to 4 of 4